Search results
Results from the WOW.Com Content Network
Insulin glulisine, sold under the brand name Apidra among others, is a rapid-acting modified form of medical insulin used for the treatment of diabetes. It differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid . [ 2 ]
Insulin glulisine was approved for medical use in the United States [51] [54] and the European Union in 2004. [53] It is currently patented by Sanofi, and is therefore only produced by said company under the brand name Apidra. [55]
Trade names: Humulin, Novolin, Insuman, others ... 2004 Sanofi Aventis Apidra insulin "glulisine" insulin ... Rapid-acting inhaled insulin is a component of the drug ...
Depression among people with diabetes remains a key health area to address. There has been recent interest in whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect depression risk.
By Sriparna Roy and Mariam Sunny (Reuters) -Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of ...
Insulin glulisine (Apidra) Examples of short-acting insulins (peak 2–4 hours) are: Regular insulin (Humulin R, Novolin R) Prompt insulin zinc (Semilente) Examples of intermediate-acting insulins (peak 4–10 hours) are: Isophane insulin, neutral protamine Hagedorn (NPH) (Humulin N, Novolin N) Insulin zinc (Lente)
More Americans with diabetes will get a break on their insulin costs in 2024. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Sign in ...
Generic drug names are given in parentheses following the brand name. – Autoimmune. ... Apidra (insulin glulisine), for type 1 and type 2 diabetes mellitus.